Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 3 UNKNOWN 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Carcinoma, Transitional Cell 1 Brain Neoplasms 1 Advanced Breast Cancer 1

Interventions

Temozolomide 2 Radiotherapy, Intensity-Modulated 2 pyrotinib 1 Vinorelbine 1 Radiation Dose Hypofractionation 1 Pharmaceutical Preparations 1 Gefitinib 1 Erlotinib Hydrochloride 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

UNKNOWN × Brain Neoplasms × pyrotinib × Clear all

NCT03933982 2019-05-29

Pyrotinib

ChineseAMS

Phase 2 Unknown

Brain Neoplasms, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡